Abstract:Ethnopharmacological relevance: Prostate cancer (PCa) is the most common malignancy of the male genitourinary system and currently lacks effective treatment. Semen Impatientis, the dried ripe seed of Impatiens balsamina L., is described by the Chinese Pharmacopoeia as a traditional Chinese medicine (TCM) and is used in clinical practice to treat tumors, abdominal masses, etc. In our previous study, the ethyl acetate extracts of Semen Impatientis (EAESI) was demonstrated to be the most effective extract against PCa among various extracts. However, the biological effects of EAESI against PCa in vivo and the specific antitumor mechanisms involved remain unknown. Aim of the study: In this study, we aimed to investigate the antitumor effect of EAESI on PCa in vitro and in vivo by performing network pharmacology analysis, transcriptomic analysis, and experiments to explore and verify the underlying mechanisms involved. Materials and methods: The antitumor effect of EAESI on PCa in vitro and in vivo was investigated via CCK-8, EdU, flow cytometry, and wound healing assays and xenograft tumor models. Network pharmacology analysis and transcriptomic analysis were employed to explore the underlying mechanism of EAESI against PCa. Activating transcription factor 3 (ATF3) and androgen receptor (AR) were confirmed to be the targets of EAESI against PCa by RT‒qPCR, western blotting, and rescue assays. In addition, the interaction between ATF3 and AR was assessed by coimmunoprecipitation, immunofluorescence, and nuclear-cytoplasmic separation assays. Results: EAESI decreased cell viability, inhibited cell proliferation and migration, and induced apoptosis in AR+ and AR- PCa cells. Moreover, EAESI suppressed the growth of xenograft tumors in vivo. Network pharmacology analysis revealed that the hub targets of EAESI against PCa included AR, AKT1, TP53, and CCND1. Transcriptomic analysis indicated that activating transcription factor 3 (ATF3) was the most likely critical target of EAESI. EAESI downregulated AR expression and decreased the transcriptional activity of AR through ATF3 in AR+ PCa cells; and EAESI promoted the expression of ATF3 and exerted its antitumor effect via ATF3 in AR+ and AR- PCa cells. Conclusions: EAESI exerts good antitumor effects on PCa both in vitro and in vivo, and ATF3 and AR are the critical targets through which EAESI exerts antitumor effects on AR+ and AR- PCa cells.

Antiprostate Cancer Activity of Ineupatolide Isolated from Carpesium Cernuum L.

Incaspitolide A Isolated From Carpesium Cernuum L. Inhibits The Growth Of Prostate Cancer Cells And Induces Apoptosis Via Regulation Of The Pi3k/Akt/Xiap Pathway

Capilliposide C Derived from Lysimachia Capillipes Hemsl Inhibits Growth of Human Prostate Cancer PC3 Cells by Targeting Caspase and MAPK Pathways.

A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells.

Preliminary evaluation of antitumor effect and induction apoptosis in PC-3 cells of extract from patrinia heterophylla

Anticancer Effect of Icaritin on Human Lung Cancer Cells Through Inducing S Phase Cell Cycle Arrest and Apoptosis.

Parthenolide Induces Proliferation Inhibition and Apoptosis of Pancreatic Cancer Cells in Vitro

Eupalinolide J Induces Apoptosis, Cell Cycle Arrest, Mitochondrial Membrane Potential Disruption and DNA Damage in Human Prostate Cancer Cells.

Incaspitolide A Extracted from Carpesium Cernuum Induces Apoptosis in Vitro Via the PI3K/AKT Pathway in Benign Prostatic Hyperplasia

Inductive effect of 20 (s)-proto-panaxdiol on apoptosis of human prostate cancer PC3 cells cultivated in vitro and its mechanism

Antitumoral action of icaritin in LNCaP prostate cancer cells by regulating PEA3/HER2/AR signaling

Experimental Therapy of Prostate Cancer with Novel Natural Product Anti-Cancer Ginsenosides

Evaluating the Therapeutic Effect of Hispidin on Prostate Cancer Cells

Aloperine Executes Antitumor Effects Through the Induction of Apoptosis and Cell Cycle Arrest in Prostate Cancer in Vitro and in Vivo

Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics

Structural Optimization of Isoquinoline Derivatives from Lycobetaine and Their Inhibitory Activity against Neuroendocrine Prostate Cancer Cells

Effects of INPP4B Gene Transfection Combined with PARP Inhibitor on Castration Therapy-Resistant Prostate Cancer Cell Line, PC3

[Inhibitory Effect of BEZ235 on Human Prostate Carcinoma in Vitro].

Carboxylesterase-overexpressing hTERT-immortalized human adipose stem cells in prostate tumor growth inhibition by irinotecan

Lg308, A Novel Synthetic Compound With Antimicrotubule Activity In Prostate Cancer Cells, Exerts Effective Antitumor Activity

Combined Inhibitory Effects of Curcumin and Phenethyl Isothiocyanate on the Growth of Human PC-3 Prostate Xenografts in Immunodeficient Mice.